smartpatient

This can help raise awareness of the benefits pharmaceutical-grade products can have for people living with certain chronic diseases. Read more on the smartpatient blog: smartpatient.eu/blog/pharmaceu…

The MyTherapy Campaign Engine can also use this targeted to help pharmaceutical-grade products manufacturers to reach patients with more relevant and targeted information.

Pharmaceutical-grade (or medical-grade) products, e.g. skin creams, can be highly effective for people living with certain chronic diseases. However, not all patients are aware of the specific benefits products can have. #pharmanews #patientengagement

Want to learn more about how MyTherapy modules boost adherence in pharma's patient communities? Check out our recent blog post on the topic at smartpatient.eu/blog/how-mythe… #pharma #launchexcellence

The above results demonstrate the impact digital tools can have regarding medication adherence. If a drug has an adherence rate of 70%, increasing it to the levels demonstrated by MyTherapy users would represent an increase of over 40%. #adherence #patientoutcomes

Treatment adherence is a major problem in the healthcare industry, costing all stakeholders, including pharma. Digital tools can help improve adherence, but many initiatives fail to have any measurable impact. #digitalhealth #pharmaindustry

Learn more about how data can help the pharmaceutical industry achieve launch excellence by reading our recent blog post on the topic: smartpatient.eu/blog/mytherapy… #PharmaMarketing #PharmaDataInsights

Our MyTherapy platform can be configured to gather qualitative and quantitative data in real-time, helping pharma make more informed decisions in the early days of a product's lifecycle that have a lasting impact. #DigitalPatientSupport #LaunchExcellence

The first months of a pharmaceutical product's lifecycle are crucial for its long-term success. Gaining insights into where new products are being prescribed, by whom, and for whom, can be hugely valuable in helping pharma make decisions. #Pharma #DigitalHealth

Want to learn more about how strategic partnerships will shape pharma's digital health ambitions in 2023? Check out this recent blog post on the smartpatient blog: smartpatient.eu/blog/how-strat… #PharmaDigitalHealth

This is a pattern that is expected to see more of in 2023, as pharma and digital health companies continue to improve at defining KPIs that validate the return on investment for digital health tools at different stages of product lifecycles and within different sectors of pharma.

#DigitalHealth investment dropped significantly in 2022, but #Pharma's partnerships with digital health firms continue to represent a sustainable model that adds value to both parties while driving the development of technology that has a genuine impact.